Arkolith/Insider Trading/ORKA/Form 4

Fairmount Funds Management LLC

Director, 10% OwnerOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$300.0M
Net Open-Market Flow
-$300.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Conversion(C)3.6M——4.7M
Jul 1, 2026Sell(S)3.6M$84.43$300.0M1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Conversion(C)43K—$094K

Transaction Codes

C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-080009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML